The pre-seed round was led by QBIT Capital and Haatch, with participation from Backbone Ventures and ROI Ventures.

The Series A round was co-led by 4impact capital and Elevator Ventures.

The Series D round was led by Highland Europe, with ECBF and McWin Capital Partners also participating as new investors.

The Series A round was led by BlueYard Capital, with participation from Founderful and XTX Ventures.

The seed round was led by VENPACE, with support from SixThirty Ventures, COREangels, and SICTIC.

The investment was backed by a renowned family office, along with participation from Greeneering Invest AG.

The Series B round was led by The Friedkin Group, with support from Alaska Airlines, Craft Ventures, Sky Dayton, and UP.Partners.

The funds are provided by Mabylon’s existing private investors, with the major investment coming from former management and board members of Roche.